New nasal vaccine for COVID-19 shows promise in animal studies

A team of University of Maryland researchers developed a nasal spray vaccine that delivers the SARS-CoV-2 spike protein into cells of the airway in mice and hamsters, triggering an immune response that significantly reduced infection and spread of COVID-19.

Related Keywords

Danielle Ellis ,Xiaoping Zhu ,University Of Maryland ,Journal Nature Communications ,Journal Nature ,Project Nextgen ,Vaccine ,Covid 19 ,Tcrn ,Immune Response ,Immune System ,Immunity ,Influenza ,Nasal Spray ,Micron ,Protein ,Research ,Espiratory ,Respiratory Syncytial Virus ,Cars ,Ars Cov 2 ,Spike Protein ,Technology ,Veterinary ,Virus ,